AIDS, Tuberculosis, and the Ebola viruses have been threatening the lives of South Africans for years. The National Institutes of Health and other health organizations have partnered to reduce the outbreak of these diseases. These organizations are awarding South African and U.S. scientists 31 grants, totaling more than $8 million dollars, during the first year.
These grants will be issued through the Collaborative Biomedical Research program with supports health issues found in both South Africa and the United States. The program is structured to nurture, and expand basic to complex medical care to South African and U.S. residents, throughout behavior, research, and scientific intervention.
The crucial areas of study are: TB, HIV and AIDS. The funding will also support research efforts at 20-United States based research facilities, and eight institutions in South Africa, including the NIH. As it now stands, South Africa is a main player in the struggle to eradicate TB and the HIV/AIDS virus.
The director of the infectious disease division, which is part of the NIH, says that the awards will attract the key major experts in both the U.S. and South Africa, and further enhance the research efforts in both diseased areas.
The director gives credence to the history of South Africa’s visionary leadership qualities, and excellence in commitment to continue cultivating biomedical research. The funding will target HIV prevention in young women, who are at risk. Prevention efforts will lower the risk of HIV. AIDS and certain cancers.
The key to prevention is to reach these women, before they get infected. The same is true for diagnosing and reaching women who are risk of contracting TB. Of the 31 awards, only 12 will provide support for the first two years of research, and the other 19 will support on- going, collaboration projects for five- years.